Login / Signup

Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma.

Kenji MiyataToshinori HoriYasuto ShimomuraMasahiro JokoMasakazu TakayasuAkihisa Okumura
Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2018)
This case highlights the efficacy and tolerability of bevacizumab for the treatment of pseudoprogression in children with spinal low-grade gliomas.
Keyphrases
  • low grade
  • high grade
  • spinal cord
  • metastatic colorectal cancer
  • young adults
  • open label
  • randomized controlled trial
  • spinal cord injury
  • replacement therapy